Clinical Trial Update: Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adefovir dipivoxil for hepatitis B in HIV-infected patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis B, HIV Infection | Phase 2 | Status: COMPLETED